Editing Snubable Enterprise (section)

=== Clone production ===
{{main|A-Series|List of clones manufactured by Snubable Enterprise}}

The AR clone system was developed by Richard Rambam from cells derived from [[Alexandru Ionuț]]. Routine production reprogrammed the cells into a totipotent-like state before assembling a synthetic embryo. Developmental acceleration was introduced into the cells themselves. The incubator provided the conditions required to sustain that program.

Early development used temporary placenta-like tissue from the reprogrammed source population. The system changed to direct vascular support after the clone's circulation reached physiological readiness. The lungs remained fluid-filled while the vascular interface oxygenated the blood. Under later factory conditions, physical maturation took about 14 days at approximately 37 °C. Neural stimulation standardized nervous-system development before later conditioning.

Snubable introduced the Maturation Synchrony Index with the deep-level maturation wing in 2008. It compared the developmental age and velocity of monitored tissues with A-Series reference profiles. A score below 80 provisionally marked the clone as defective during incubation, but final classification still followed physical and cognitive evaluation after removal.

[[Paul Norggohole]] joined Snubable Enterprise as a senior cellular-reprogramming researcher on 1 October 2010. He separated the master cell banks from the working cultures used in clone production. [[Richard Rambam]] appointed him Head of Developmental Cell Biology on 15 March 2011. His department handled cellular reprogramming before production and designed the developmental screening used for the A-Series.<ref name="paul-snubable"/>

Most Snubable clones were pale and bald, with a deliberately uniform appearance. Blue eyes were common. Units with deformities, structural weakness or inadequate cognitive performance were classified as Jester clones. They were assigned hazardous or low-level work inside controlled facilities. Standard clones met the baseline requirements and formed most of the clone population. They performed routine work inside facilities and were used for transport or perimeter duties. Elite clones showed greater physical stability and cognitive performance and were selected for armed security and combat assignments. Standard and Elite clones generally wore black synthetic suits with white shirts and ties. Armed units received body armor or reinforced versions of the same clothing.

After Pușcaș became Lead Thermal Engineer, he asked Snubable to assign him an adult female clone he had seen in an incubation area. The organization approved the transfer. Pușcaș repeatedly raped her while she was under his control and struck her when she resisted.

Each clone was registered under a standardized serial structure:

<pre>
AR-XXX-LLLLNNNN
</pre>

'''AR''' identified the Alexandru Rambam lineage. '''XXX''' recorded the production batch, '''LLLL''' identified the genetic or cognitive classification block and '''NNNN''' was the individual unit number. The complete code was entered into Snubable's central records with the clone's production information and operational status.

Post-mortem work in 2009 identified A-Series ischemic degeneration syndrome as a recurring microvascular disease. Routine whole-transcriptome monitoring for ischemic stress began in 2011. Later lineage instability increased as culture-selected changes entered replacement master banks. Rambam began the B-Series stabilization project in 2023 from archived early A-Series stock, but its physically mature prototypes retained incomplete microvascular maturation and never entered industrial production.